The recent disruptions in global chains have highlighted the importance of securing vital medications like Ivermectin. Dependence on overseas manufacturers exposes regions to considerable vulnerabilities, including transportation delays, cost fluctuations, and even geopolitical threats. Transitioning towards domestic production of Ivermectin offers